Paulo Fontoura resigns from Lakefront Biotherapeutics board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- S&P 500, Nasdaq fall as chips extend losses; earnings and data in focus
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil prices dip but hold near highest in a month on Middle East tensions
- Citi sees Google, Meta and Amazon capex spending at over $800 billion in 2027
- UnitedHealth shares surge on strong earnings beat and guidance
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
July 13, 2026 4:01 PM EDTMechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo Fontoura has tendered his resignation from the Board of Directors.
I want to congratulate Paulo on this important assignment and sincerely thank him for his insight and guidance during his tenure on our Board, said Gino Santini, Chair of the Board of Directors. We wish him the best of luck in his new position and we expect to appoint a successor at the... More
